Literature DB >> 8440716

Organization of the human gene encoding the cytoskeletal protein vinculin and the sequence of the vinculin promoter.

E P Moiseyeva1, P A Weller, N I Zhidkova, E B Corben, B Patel, I Jasinska, V E Koteliansky, D R Critchley.   

Abstract

The human vinculin gene contains 22 exons ranging in size from 71 base pairs (bp) to 303 bp (average 155 bp) with the exception of exon 22 which contains 144 bp of coding sequence and 1848 bp of 3'-untranslated sequence including two polyadenylation signals. There is a limited correlation between exon boundaries and functional domains within the vinculin molecule. The talin-binding domain in vinculin spans residues 1-258, and the first 6 exons encode residues 1-261. Similarly, the predicted boundaries of the central repeat domain (residues 259-589) are close to the boundaries of exons 7 and 12. Analysis of vinculin mRNAs in human uterus showed that alternative splicing of the gene is limited to exon 19, which encodes the 68 amino acids included in the muscle-specific isoform called metavinculin. We have determined 1.1 kilobases of sequence 5' of the transcription start site. The vinculin promoter lacks a TATA box, but does contain six Sp1 sites, and a CArG box at position -262 which forms the core of the serum response element found in immediate-early response genes. Expression of a vinculin promoter/CAT construct is serum-inducible in NIH3T3 cells demonstrating that the promoter does contain a functional serum response element.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Smooth muscle alternative splicing induced in fibroblasts by heterologous expression of a regulatory gene.

Authors:  G C Roberts; C Gooding; C W Smith
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

2.  Talin contains three similar vinculin-binding sites predicted to form an amphipathic helix.

Authors:  M D Bass; B J Smith; S A Prigent; D R Critchley
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 3.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation.

Authors:  K Sobue; K Hayashi; W Nishida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Acidic phospholipids inhibit the intramolecular association between the N- and C-terminal regions of vinculin, exposing actin-binding and protein kinase C phosphorylation sites.

Authors:  J Weekes; S T Barry; D R Critchley
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

Review 5.  Vinculin, cadherin mechanotransduction and homeostasis of cell-cell junctions.

Authors:  Joanne M Leerberg; Alpha S Yap
Journal:  Protoplasma       Date:  2012-12-29       Impact factor: 3.356

6.  Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy.

Authors:  Alice E Zemljic-Harpf; Sornya Ponrartana; Roy T Avalos; Maria C Jordan; Kenneth P Roos; Nancy D Dalton; Vinh Q Phan; Eileen D Adamson; Robert S Ross
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

7.  The vinculin-DeltaIn20/21 mouse: characteristics of a constitutive, actin-binding deficient splice variant of vinculin.

Authors:  Susanna Marg; Ulrike Winkler; Marcello Sestu; Mirko Himmel; Madeleine Schönherr; Janina Bär; Amrit Mann; Markus Moser; Claudia T Mierke; Klemens Rottner; Manfred Blessing; Johannes Hirrlinger; Wolfgang H Ziegler
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

8.  Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy.

Authors:  Alice E Zemljic-Harpf; Joel C Miller; Scott A Henderson; Adam T Wright; Ana Maria Manso; Laila Elsherif; Nancy D Dalton; Andrea K Thor; Guy A Perkins; Andrew D McCulloch; Robert S Ross
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  Distinct activities of the alpha-catenin family, alpha-catulin and alpha-catenin, on beta-catenin-mediated signaling.

Authors:  Keith D Merdek; Nhan T Nguyen; Deniz Toksoz
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Familial dilated cardiomyopathy associated with congenital defects in the setting of a novel VCL mutation (Lys815Arg) in conjunction with a known MYPBC3 variant.

Authors:  Quinn S Wells; Natalie L Ausborn; Birgit H Funke; Jean P Pfotenhauer; Joseph L Fredi; Samantha Baxter; Thomas D Disalvo; Charles C Hong
Journal:  Cardiogenetics       Date:  2011-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.